v3.25.3
INVESTMENTS (Narrative) (Details) - USD ($)
$ in Thousands
 1 Months Ended 12 Months Ended
Jan. 31, 2023
Dec. 31, 2023
Jun. 30, 2025
Dec. 31, 2024
Investments in and Advances to Affiliates [Line Items]        
Total investment     $ 347 $ 277
Arrow Ecology & Engineering Overseas (1999) [Member]        
Investments in and Advances to Affiliates [Line Items]        
Shareholders loans     $ 4,146  
Price paid for debt   $ 1,750    
Ownership interest   22.60% 22.60% [1] 22.60% [1]
Total investment     $ 0  
Guaranteed to repurchase full investment     1,750  
Manuka, Inc. (Previously Artemis Therapeutics, Inc.) [Member]        
Investments in and Advances to Affiliates [Line Items]        
Market value     0 $ 0
Capital Fund Aims To Invest In Private Emerging Companies With Focus On Consumer, Commerce And Technology Companies [Member]        
Investments in and Advances to Affiliates [Line Items]        
Total investment     78  
Committed to invest     $ 100  
Sardinai [Member]        
Investments in and Advances to Affiliates [Line Items]        
Percentage of investment sold 85.00%      
Investment sold $ 756      
[1] The investment includes few types of shares representing 22.6% of Arrow’s equity and shareholders loans of $4,146 which were purchased for a total amount of $1,750. The Company suspended its use of the equity method for this investment in 2023 after its investment balance was reduced to zero. The Company has an agreement with an entity related to its main shareholder, according to which, if the value of the investment decrease, the related party entity has guaranteed to repurchase this full investment at a minimum amount of $1,750. The guarantee is effective immediately as of the date of purchase and terminates on January 1, 2027. Some Directors, managers and shareholders of Arrow are related parties of the Company.